Global Nasal Spray Live Attenuated Influenza Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 109
Published Date: 08 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Nasal Spray Live Attenuated Influenza Vaccine market size was valued at USD 739.3 million in 2023 and is forecast to a readjusted size of USD 1149.4 million by 2030 with a CAGR of 6.5% during review period.
Nasal Spray Live Attenuated Influenza Vaccine (LAIV), often marketed under the brand name FluMist, is a type of influenza vaccine designed to protect against the influenza virus. Unlike traditional injectable influenza vaccines, which contain inactivated (killed) virus particles, LAIV contains a weakened, live influenza virus. This live virus is attenuated, meaning it has been modified to reduce its virulence (ability to cause disease) while still retaining the capacity to stimulate an immune response.
Fluctuating Usage: The use of LAIV has seen fluctuations in recent years. In the United States, for example, there was a period when the Advisory Committee on Immunization Practices (ACIP) recommended against the use of LAIV due to concerns about its effectiveness against certain influenza strains. Subsequently, ACIP reinstated its recommendation for LAIV, but these fluctuations have had an impact on the market.
Pediatric Vaccination: LAIV has been particularly popular for pediatric vaccination. Its non-invasive administration method (nasal spray) has made it a preferred choice for children who may have needle phobias or resistance to traditional injectable vaccines.
Global Market Variation: The availability and popularity of LAIV can vary by country and region. Some countries have embraced LAIV more enthusiastically than others, influenced by factors like regulatory approvals, healthcare policies, and local preferences.
Combination Vaccines: Research is ongoing in developing combination vaccines that may include LAIV alongside other vaccines, such as those for COVID-19. These combination vaccines aim to simplify the vaccination process and increase immunization coverage.
The Global Info Research report includes an overview of the development of the Nasal Spray Live Attenuated Influenza Vaccine industry chain, the market status of Hospital (Trivalent Flu Vaccine, Quadrivalent Flu Vaccine), Clinic (Trivalent Flu Vaccine, Quadrivalent Flu Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Nasal Spray Live Attenuated Influenza Vaccine.
Regionally, the report analyzes the Nasal Spray Live Attenuated Influenza Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Nasal Spray Live Attenuated Influenza Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Nasal Spray Live Attenuated Influenza Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Nasal Spray Live Attenuated Influenza Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K L), revenue generated, and market share of different by Type (e.g., Trivalent Flu Vaccine, Quadrivalent Flu Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Nasal Spray Live Attenuated Influenza Vaccine market.
Regional Analysis: The report involves examining the Nasal Spray Live Attenuated Influenza Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Nasal Spray Live Attenuated Influenza Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Nasal Spray Live Attenuated Influenza Vaccine:
Company Analysis: Report covers individual Nasal Spray Live Attenuated Influenza Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Nasal Spray Live Attenuated Influenza Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Nasal Spray Live Attenuated Influenza Vaccine. It assesses the current state, advancements, and potential future developments in Nasal Spray Live Attenuated Influenza Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Nasal Spray Live Attenuated Influenza Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Nasal Spray Live Attenuated Influenza Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Trivalent Flu Vaccine
Quadrivalent Flu Vaccine
Market segment by Application
Hospital
Clinic
Public Health Agency
Others
Major players covered
Sanofi Pasteur
AstraZeneca
CSL
Abbott
GlaxoSmithKline
Serum Institute
Fluenz Tetra
BioDiem
FluMist
ChangChun High & New Technology
BCHT Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nasal Spray Live Attenuated Influenza Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Nasal Spray Live Attenuated Influenza Vaccine, with price, sales, revenue and global market share of Nasal Spray Live Attenuated Influenza Vaccine from 2019 to 2024.
Chapter 3, the Nasal Spray Live Attenuated Influenza Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nasal Spray Live Attenuated Influenza Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Nasal Spray Live Attenuated Influenza Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Nasal Spray Live Attenuated Influenza Vaccine.
Chapter 14 and 15, to describe Nasal Spray Live Attenuated Influenza Vaccine sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Nasal Spray Live Attenuated Influenza Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Trivalent Flu Vaccine
1.3.3 Quadrivalent Flu Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Public Health Agency
1.4.5 Others
1.5 Global Nasal Spray Live Attenuated Influenza Vaccine Market Size & Forecast
1.5.1 Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity (2019-2030)
1.5.3 Global Nasal Spray Live Attenuated Influenza Vaccine Average Price (2019-2030)
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Product and Services
2.1.4 Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sanofi Pasteur Recent Developments/Updates
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Product and Services
2.2.4 AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 AstraZeneca Recent Developments/Updates
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Nasal Spray Live Attenuated Influenza Vaccine Product and Services
2.3.4 CSL Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 CSL Recent Developments/Updates
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Nasal Spray Live Attenuated Influenza Vaccine Product and Services
2.4.4 Abbott Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Abbott Recent Developments/Updates
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Product and Services
2.5.4 GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 GlaxoSmithKline Recent Developments/Updates
2.6 Serum Institute
2.6.1 Serum Institute Details
2.6.2 Serum Institute Major Business
2.6.3 Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Product and Services
2.6.4 Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Serum Institute Recent Developments/Updates
2.7 Fluenz Tetra
2.7.1 Fluenz Tetra Details
2.7.2 Fluenz Tetra Major Business
2.7.3 Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Product and Services
2.7.4 Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Fluenz Tetra Recent Developments/Updates
2.8 BioDiem
2.8.1 BioDiem Details
2.8.2 BioDiem Major Business
2.8.3 BioDiem Nasal Spray Live Attenuated Influenza Vaccine Product and Services
2.8.4 BioDiem Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 BioDiem Recent Developments/Updates
2.9 FluMist
2.9.1 FluMist Details
2.9.2 FluMist Major Business
2.9.3 FluMist Nasal Spray Live Attenuated Influenza Vaccine Product and Services
2.9.4 FluMist Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 FluMist Recent Developments/Updates
2.10 ChangChun High & New Technology
2.10.1 ChangChun High & New Technology Details
2.10.2 ChangChun High & New Technology Major Business
2.10.3 ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Product and Services
2.10.4 ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 ChangChun High & New Technology Recent Developments/Updates
2.11 BCHT Biotechnology
2.11.1 BCHT Biotechnology Details
2.11.2 BCHT Biotechnology Major Business
2.11.3 BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Product and Services
2.11.4 BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 BCHT Biotechnology Recent Developments/Updates
3.1 Global Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Nasal Spray Live Attenuated Influenza Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Nasal Spray Live Attenuated Influenza Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Nasal Spray Live Attenuated Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Nasal Spray Live Attenuated Influenza Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Nasal Spray Live Attenuated Influenza Vaccine Manufacturer Market Share in 2023
3.5 Nasal Spray Live Attenuated Influenza Vaccine Market: Overall Company Footprint Analysis
3.5.1 Nasal Spray Live Attenuated Influenza Vaccine Market: Region Footprint
3.5.2 Nasal Spray Live Attenuated Influenza Vaccine Market: Company Product Type Footprint
3.5.3 Nasal Spray Live Attenuated Influenza Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Nasal Spray Live Attenuated Influenza Vaccine Market Size by Region
4.1.1 Global Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Nasal Spray Live Attenuated Influenza Vaccine Average Price by Region (2019-2030)
4.2 North America Nasal Spray Live Attenuated Influenza Vaccine Consumption Value (2019-2030)
4.3 Europe Nasal Spray Live Attenuated Influenza Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Nasal Spray Live Attenuated Influenza Vaccine Consumption Value (2019-2030)
4.5 South America Nasal Spray Live Attenuated Influenza Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Nasal Spray Live Attenuated Influenza Vaccine Consumption Value (2019-2030)
5.1 Global Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Type (2019-2030)
5.3 Global Nasal Spray Live Attenuated Influenza Vaccine Average Price by Type (2019-2030)
6.1 Global Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Application (2019-2030)
6.3 Global Nasal Spray Live Attenuated Influenza Vaccine Average Price by Application (2019-2030)
7.1 North America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Nasal Spray Live Attenuated Influenza Vaccine Market Size by Country
7.3.1 North America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Nasal Spray Live Attenuated Influenza Vaccine Market Size by Country
8.3.1 Europe Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Nasal Spray Live Attenuated Influenza Vaccine Market Size by Region
9.3.1 Asia-Pacific Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Nasal Spray Live Attenuated Influenza Vaccine Market Size by Country
10.3.1 South America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Market Size by Country
11.3.1 Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Nasal Spray Live Attenuated Influenza Vaccine Market Drivers
12.2 Nasal Spray Live Attenuated Influenza Vaccine Market Restraints
12.3 Nasal Spray Live Attenuated Influenza Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Nasal Spray Live Attenuated Influenza Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Nasal Spray Live Attenuated Influenza Vaccine
13.3 Nasal Spray Live Attenuated Influenza Vaccine Production Process
13.4 Nasal Spray Live Attenuated Influenza Vaccine Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Nasal Spray Live Attenuated Influenza Vaccine Typical Distributors
14.3 Nasal Spray Live Attenuated Influenza Vaccine Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Major Business
Table 5. Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 6. Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity (K L), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Sanofi Pasteur Recent Developments/Updates
Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca Major Business
Table 10. AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 11. AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity (K L), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. AstraZeneca Recent Developments/Updates
Table 13. CSL Basic Information, Manufacturing Base and Competitors
Table 14. CSL Major Business
Table 15. CSL Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 16. CSL Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity (K L), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. CSL Recent Developments/Updates
Table 18. Abbott Basic Information, Manufacturing Base and Competitors
Table 19. Abbott Major Business
Table 20. Abbott Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 21. Abbott Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity (K L), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Abbott Recent Developments/Updates
Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline Major Business
Table 25. GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 26. GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity (K L), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. GlaxoSmithKline Recent Developments/Updates
Table 28. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 29. Serum Institute Major Business
Table 30. Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 31. Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity (K L), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Serum Institute Recent Developments/Updates
Table 33. Fluenz Tetra Basic Information, Manufacturing Base and Competitors
Table 34. Fluenz Tetra Major Business
Table 35. Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 36. Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity (K L), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Fluenz Tetra Recent Developments/Updates
Table 38. BioDiem Basic Information, Manufacturing Base and Competitors
Table 39. BioDiem Major Business
Table 40. BioDiem Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 41. BioDiem Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity (K L), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. BioDiem Recent Developments/Updates
Table 43. FluMist Basic Information, Manufacturing Base and Competitors
Table 44. FluMist Major Business
Table 45. FluMist Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 46. FluMist Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity (K L), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. FluMist Recent Developments/Updates
Table 48. ChangChun High & New Technology Basic Information, Manufacturing Base and Competitors
Table 49. ChangChun High & New Technology Major Business
Table 50. ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 51. ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity (K L), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. ChangChun High & New Technology Recent Developments/Updates
Table 53. BCHT Biotechnology Basic Information, Manufacturing Base and Competitors
Table 54. BCHT Biotechnology Major Business
Table 55. BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 56. BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity (K L), Average Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. BCHT Biotechnology Recent Developments/Updates
Table 58. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Manufacturer (2019-2024) & (K L)
Table 59. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 60. Global Nasal Spray Live Attenuated Influenza Vaccine Average Price by Manufacturer (2019-2024) & (US$/ml)
Table 61. Market Position of Manufacturers in Nasal Spray Live Attenuated Influenza Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 62. Head Office and Nasal Spray Live Attenuated Influenza Vaccine Production Site of Key Manufacturer
Table 63. Nasal Spray Live Attenuated Influenza Vaccine Market: Company Product Type Footprint
Table 64. Nasal Spray Live Attenuated Influenza Vaccine Market: Company Product Application Footprint
Table 65. Nasal Spray Live Attenuated Influenza Vaccine New Market Entrants and Barriers to Market Entry
Table 66. Nasal Spray Live Attenuated Influenza Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Region (2019-2024) & (K L)
Table 68. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Region (2025-2030) & (K L)
Table 69. Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 70. Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 71. Global Nasal Spray Live Attenuated Influenza Vaccine Average Price by Region (2019-2024) & (US$/ml)
Table 72. Global Nasal Spray Live Attenuated Influenza Vaccine Average Price by Region (2025-2030) & (US$/ml)
Table 73. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Type (2019-2024) & (K L)
Table 74. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Type (2025-2030) & (K L)
Table 75. Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Global Nasal Spray Live Attenuated Influenza Vaccine Average Price by Type (2019-2024) & (US$/ml)
Table 78. Global Nasal Spray Live Attenuated Influenza Vaccine Average Price by Type (2025-2030) & (US$/ml)
Table 79. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Application (2019-2024) & (K L)
Table 80. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Application (2025-2030) & (K L)
Table 81. Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 82. Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 83. Global Nasal Spray Live Attenuated Influenza Vaccine Average Price by Application (2019-2024) & (US$/ml)
Table 84. Global Nasal Spray Live Attenuated Influenza Vaccine Average Price by Application (2025-2030) & (US$/ml)
Table 85. North America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Type (2019-2024) & (K L)
Table 86. North America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Type (2025-2030) & (K L)
Table 87. North America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Application (2019-2024) & (K L)
Table 88. North America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Application (2025-2030) & (K L)
Table 89. North America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Country (2019-2024) & (K L)
Table 90. North America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Country (2025-2030) & (K L)
Table 91. North America Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 92. North America Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Type (2019-2024) & (K L)
Table 94. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Type (2025-2030) & (K L)
Table 95. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Application (2019-2024) & (K L)
Table 96. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Application (2025-2030) & (K L)
Table 97. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Country (2019-2024) & (K L)
Table 98. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Country (2025-2030) & (K L)
Table 99. Europe Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Type (2019-2024) & (K L)
Table 102. Asia-Pacific Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Type (2025-2030) & (K L)
Table 103. Asia-Pacific Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Application (2019-2024) & (K L)
Table 104. Asia-Pacific Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Application (2025-2030) & (K L)
Table 105. Asia-Pacific Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Region (2019-2024) & (K L)
Table 106. Asia-Pacific Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Region (2025-2030) & (K L)
Table 107. Asia-Pacific Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 108. Asia-Pacific Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 109. South America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Type (2019-2024) & (K L)
Table 110. South America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Type (2025-2030) & (K L)
Table 111. South America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Application (2019-2024) & (K L)
Table 112. South America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Application (2025-2030) & (K L)
Table 113. South America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Country (2019-2024) & (K L)
Table 114. South America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Country (2025-2030) & (K L)
Table 115. South America Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 116. South America Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 117. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Type (2019-2024) & (K L)
Table 118. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Type (2025-2030) & (K L)
Table 119. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Application (2019-2024) & (K L)
Table 120. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Application (2025-2030) & (K L)
Table 121. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Region (2019-2024) & (K L)
Table 122. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity by Region (2025-2030) & (K L)
Table 123. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 124. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 125. Nasal Spray Live Attenuated Influenza Vaccine Raw Material
Table 126. Key Manufacturers of Nasal Spray Live Attenuated Influenza Vaccine Raw Materials
Table 127. Nasal Spray Live Attenuated Influenza Vaccine Typical Distributors
Table 128. Nasal Spray Live Attenuated Influenza Vaccine Typical Customers
List of Figures
Figure 1. Nasal Spray Live Attenuated Influenza Vaccine Picture
Figure 2. Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Trivalent Flu Vaccine Examples
Figure 5. Quadrivalent Flu Vaccine Examples
Figure 6. Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value Market Share by Application in 2023
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Public Health Agency Examples
Figure 11. Others Examples
Figure 12. Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity (2019-2030) & (K L)
Figure 15. Global Nasal Spray Live Attenuated Influenza Vaccine Average Price (2019-2030) & (US$/ml)
Figure 16. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Nasal Spray Live Attenuated Influenza Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Nasal Spray Live Attenuated Influenza Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Nasal Spray Live Attenuated Influenza Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Nasal Spray Live Attenuated Influenza Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Nasal Spray Live Attenuated Influenza Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Nasal Spray Live Attenuated Influenza Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Nasal Spray Live Attenuated Influenza Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Nasal Spray Live Attenuated Influenza Vaccine Average Price by Type (2019-2030) & (US$/ml)
Figure 31. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Nasal Spray Live Attenuated Influenza Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Nasal Spray Live Attenuated Influenza Vaccine Average Price by Application (2019-2030) & (US$/ml)
Figure 34. North America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Nasal Spray Live Attenuated Influenza Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Nasal Spray Live Attenuated Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Nasal Spray Live Attenuated Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Nasal Spray Live Attenuated Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Nasal Spray Live Attenuated Influenza Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Nasal Spray Live Attenuated Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Nasal Spray Live Attenuated Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Nasal Spray Live Attenuated Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Nasal Spray Live Attenuated Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Nasal Spray Live Attenuated Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Nasal Spray Live Attenuated Influenza Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 54. China Nasal Spray Live Attenuated Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Nasal Spray Live Attenuated Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Nasal Spray Live Attenuated Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Nasal Spray Live Attenuated Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Nasal Spray Live Attenuated Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Nasal Spray Live Attenuated Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Nasal Spray Live Attenuated Influenza Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Nasal Spray Live Attenuated Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Nasal Spray Live Attenuated Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Nasal Spray Live Attenuated Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Nasal Spray Live Attenuated Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Nasal Spray Live Attenuated Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Nasal Spray Live Attenuated Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Nasal Spray Live Attenuated Influenza Vaccine Market Drivers
Figure 75. Nasal Spray Live Attenuated Influenza Vaccine Market Restraints
Figure 76. Nasal Spray Live Attenuated Influenza Vaccine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Nasal Spray Live Attenuated Influenza Vaccine in 2023
Figure 79. Manufacturing Process Analysis of Nasal Spray Live Attenuated Influenza Vaccine
Figure 80. Nasal Spray Live Attenuated Influenza Vaccine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Sanofi Pasteur AstraZeneca CSL Abbott GlaxoSmithKline Serum Institute Fluenz Tetra BioDiem FluMist ChangChun High & New Technology BCHT Biotechnology
19 Feb 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
